You are here
A REMS for Long-Acting Opioid Analgesics: Anticipated Impact on the Dual Public Health Issues of Non-Medical Use and Patient Pain Care
Aaron M. Gilson
Journal of Pain and Symptom Management, Volume 39, Issue 2, February 2010, p370
- Discuss principal characteristics of the FDA's implemented REMS program.
- Discuss how the current REMS program is able to respond to prescription opioid medication abuse and diversion.
- Discuss how the current REMS program can influence legitimate prescribing of opioid medications for patient pain relief.